Clinical Trial Results: Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF [Phase 4]

View source ↗

Summary

Phase 4 trial comparing PolarX and Arctic Front cryoballoons for pulmonary vein isolation in symptomatic paroxysmal atrial fibrillation. Results completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• Arctic Front
• POLARx

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Paroxysmal Atrial Fibrillation | Phase 4 | Status: COMPLETED | Results posted: 2026-07-24